We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase II Trial of SNG001 in Coronavirus Patients Set To Start

News   Mar 18, 2020 | Original story from Synairgen

 
Phase II Trial of SNG001 in Coronavirus Patients Set To Start

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Food and Drug Allergy Anaphylaxis Could Be Prevented With a Pill

News

A new study suggested a pill could be taken proactively to prevent mild to life-threatening anaphylaxis.

READ MORE

Clinical Trials in an Era of Digital Engagement

News

Researchers from SWOG Cancer Research Network pose provocative questions aimed at sparking discussion and creating consensus on how cancer clinical trial stakeholders can best interact on social platforms.

READ MORE

New Insight Into Metformin's Mode of Action As Anti-diabetic Drug

News

A research team has discovered that metformin, the most widely prescribed anti-diabetic drug, causes sugar to be excreted in the stool.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE